China Pioneer Pharma Takes the First Move to Rekindle Patients' Hopes
HONG KONG, Apr 1, 2015 - (ACN Newswire) - China Pioneer Pharma Holdings Limited, one of the largest comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, is pleased to announce that NeutroPhase, a skin and wound cleanser exclusively marketed, promoted and distributed by the Group in mainland China and parts of Southeast Asia, was recently named as the official wound cleanser of the National Necrotizing Fasciitis Foundation (NNFF) in the United States. The Group has already teamed up with NNFF and the product manufacturer - NovaBay Pharmaceuticals, Inc. to offer NeutroPhase and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region in order to enable doctors to save life of patients as quick as possible and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma first introduced NeutroPhase in mainland China in September 2014 to patients who suffered from diabetic foot ulcers and burns for clinical trial applications for a short period of time. The cleanser was immediately recognized by both the doctors and patients. A number of doctors, such as Dr. Yang Qianyong and Dr. Li Qi, Directors of Department of Endocrinology of Chinese People's Liberation Army No. 94 Hospital, and Dr. Hao Jianhua, Orthopedic physician of Chinese People's Liberation Army No. 254 Hospital and so on, approbates NeutroPhase for its significant medical effects on the diabetic foot ulcers wounds with accolades and commendations.
NeutroPhase was pioneered for the treatment of necrotizing fasciitis. It does not only kill bacteria, but also neutralizes the toxins produced by both bacteria and the immune system, stopping the spread of dead tissue.
Mr. LI Xinzhou, Chairman and Executive Director of China Pioneer Pharma said: "NeutroPhase being named the official wound cleanser of the NNFF can further recognize its active ingredients, rekindles hopes for flesh-eating disease patients and bring major improvement in global medical care industry. Looking ahead, we will continue to provide NeutroPhase and relevant medical guidance to patients in need and lead them on the road to recovery."
Source: China Pioneer Pharma Holdings Limited
Copyright 2015 ACN Newswire . All rights reserved.
